TARA

2.2805.00%
JS

Jesse Shefferman

Co-founder, CEO, President & Director

Mr. Jesse Shefferman serves as Chief Executive Officer, President and Director of Protara Therapeutics, Inc. (Formerly known as Proteon Therapeutics Inc.) since January 2020. He Co-founded Protara Therapeutics, Inc. He co-founded ArTara Therapeutics, Inc. and served as its Chief Executive Officer and Director since November 2017 until January 2020. He served as its Principal Financial Officer of Protara Therapeutics, Inc. since July 16, 2022 until January 30, 2023. He was an Equity Analyst at Crédit Suisse AG, Research Division. He was at the firm from 1997 – 1999. Mr. Shefferman served as an Equity Analyst at Citigroup Inc, Research Division. He has spent over a decade in the biopharma industry in strategy and financial roles, most of that time focused on rare and orphan diseases. He was Vice President and Head of Business Development at Retrophin Inc. (RTRX) since March 2014 until October 2017 a leading rare diseases company where he was a Member of the executive leadership team and led the team that identified and executed a number of company-defining transactions. Prior to Retrophin, he was with Vertex Pharmaceuticals (VRTX) in Business Development and Corporate Strategy where he focused on the hepatology and rare diseases sectors. He was previously an investment banker with Barclays Capital and Lehman Brothers where he focused on providing strategic and financial advice to management teams and boards of Directors of biopharmaceutical companies. He holds an MBA and certificate in health sector management from Duke University and a BA in Accounting from Gordon College.

Positions